127 related articles for article (PubMed ID: 27355852)
21.
Herlemann A; Wenter V; Kretschmer A; Thierfelder KM; Bartenstein P; Faber C; Gildehaus FJ; Stief CG; Gratzke C; Fendler WP
Eur Urol; 2016 Oct; 70(4):553-557. PubMed ID: 26810345
[TBL] [Abstract][Full Text] [Related]
22. Comparison of PSMA-ligand PET/CT and multiparametric MRI for the detection of recurrent prostate cancer in the pelvis.
Afshar-Oromieh A; Vollnberg B; Alberts I; Bähler A; Sachpekidis C; Dijkstra L; Haupt F; Boxler S; Gross T; Holland-Letz T; Thalmann G; Heverhagen J; Rominger A; Härmä K; Maurer MH
Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2289-2297. PubMed ID: 31350604
[TBL] [Abstract][Full Text] [Related]
23. 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.
Eder M; Schäfer M; Bauder-Wüst U; Hull WE; Wängler C; Mier W; Haberkorn U; Eisenhut M
Bioconjug Chem; 2012 Apr; 23(4):688-97. PubMed ID: 22369515
[TBL] [Abstract][Full Text] [Related]
24. Uptake in non-affected bone tissue does not differ between [18F]-DCFPyL and [68Ga]-HBED-CC PSMA PET/CT.
Hammes J; Hohberg M; Täger P; Wild M; Zlatopolskiy B; Krapf P; Neumaier B; Schomäcker K; Kobe C; Schmidt M; Dietlein M; Drzezga A
PLoS One; 2018; 13(12):e0209613. PubMed ID: 30571794
[TBL] [Abstract][Full Text] [Related]
25. Subacute Cerebellar Infarction With Uptake on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
Oh G; Miles K
Clin Nucl Med; 2018 Feb; 43(2):134-135. PubMed ID: 29261628
[TBL] [Abstract][Full Text] [Related]
26. Large Paraesophageal Schwannoma With Intense Prostate-Specific Membrane Antigen Expression on 68Ga-PSMA-PET/CT Mimicking Lymph Node Metastasis in a Patient With Prostate Cancer.
Ries M; Khreish F; Veith C; von den Hoff J; Ezziddin S
Clin Nucl Med; 2019 Feb; 44(2):153-154. PubMed ID: 30371596
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous
Eiber M; Weirich G; Holzapfel K; Souvatzoglou M; Haller B; Rauscher I; Beer AJ; Wester HJ; Gschwend J; Schwaiger M; Maurer T
Eur Urol; 2016 Nov; 70(5):829-836. PubMed ID: 26795686
[TBL] [Abstract][Full Text] [Related]
28. Early Detection of Bilateral Testicular Metastases From Prostatic Adenocarcinoma Using 68Ga-PSMA Ligand PET/CT.
Weiberg D; Radner H; Derlin T; Thon WF
Clin Nucl Med; 2017 Jul; 42(7):563-564. PubMed ID: 28368893
[TBL] [Abstract][Full Text] [Related]
29. Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
Morigi JJ; Stricker PD; van Leeuwen PJ; Tang R; Ho B; Nguyen Q; Hruby G; Fogarty G; Jagavkar R; Kneebone A; Hickey A; Fanti S; Tarlinton L; Emmett L
J Nucl Med; 2015 Aug; 56(8):1185-90. PubMed ID: 26112024
[TBL] [Abstract][Full Text] [Related]
30. Could 68-Ga PSMA PET/CT become a new tool in the decision-making strategy of prostate cancer patients with biochemical recurrence of PSA after radical prostatectomy? A preliminary, monocentric series.
De Bari B; Mazzola R; Aiello D; Fersino S; Gregucci F; Alongi P; Nicodemo M; Cavalleri S; Salgarello M; Alongi F
Radiol Med; 2018 Sep; 123(9):719-725. PubMed ID: 29687208
[TBL] [Abstract][Full Text] [Related]
31. Vertebral Myeloma Mimicking Prostatic Carcinoma Metastasis in 68Ga-PSMA PET/CT.
Merrild EH; Baerentzen S; Bouchelouche K; Buus S
Clin Nucl Med; 2017 Oct; 42(10):790-792. PubMed ID: 28737577
[TBL] [Abstract][Full Text] [Related]
32. Intense PSMA-expression using (68)Ga-PSMA PET/CT in a paravertebral schwannoma mimicking prostate cancer metastasis.
Rischpler C; Maurer T; Schwaiger M; Eiber M
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):193-194. PubMed ID: 26502982
[No Abstract] [Full Text] [Related]
33. Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer.
Sanli Y; Kuyumcu S; Sanli O; Buyukkaya F; İribaş A; Alcin G; Darendeliler E; Ozluk Y; Yildiz SO; Turkmen C
Ann Nucl Med; 2017 Nov; 31(9):709-717. PubMed ID: 28900854
[TBL] [Abstract][Full Text] [Related]
34. Bone Infarction Mimicking a Bone Metastasis on 18F-Prostate-Specific Membrane Antigen PET/CT.
Elsobky S; Nathan M; Robertson N; Wagner T
Clin Nucl Med; 2021 May; 46(5):e250-e252. PubMed ID: 33323731
[TBL] [Abstract][Full Text] [Related]
35. Validation of a [Al
Al-Momani E; Israel I; Samnick S
Appl Radiat Isot; 2017 Dec; 130():102-108. PubMed ID: 28950199
[TBL] [Abstract][Full Text] [Related]
36. Optimization of Labeling PSMA
Eppard E; Homann T; de la Fuente A; Essler M; Rösch F
J Nucl Med; 2017 Mar; 58(3):432-437. PubMed ID: 28082433
[TBL] [Abstract][Full Text] [Related]
37. Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA.
Ray Banerjee S; Chen Z; Pullambhatla M; Lisok A; Chen J; Mease RC; Pomper MG
Bioconjug Chem; 2016 Jun; 27(6):1447-55. PubMed ID: 27076393
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using
Zamboglou C; Sachpazidis I; Koubar K; Drendel V; Wiehle R; Kirste S; Mix M; Schiller F; Mavroidis P; Meyer PT; Werner M; Grosu AL; Baltas D
Radiother Oncol; 2017 Jun; 123(3):472-477. PubMed ID: 28499607
[TBL] [Abstract][Full Text] [Related]
39. Abdominal Splenosis Mimicking Peritoneal Metastasis in Prostate-Specific Membrane Antigen PET/CT, Confirmed With Selective Spleen SPECT/CT.
Demirci E; Has Simsek D; Kabasakal L; Mülazimoğlu M
Clin Nucl Med; 2017 Dec; 42(12):e504-e505. PubMed ID: 29076911
[TBL] [Abstract][Full Text] [Related]
40. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD
BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]